Oncolytics Biotech Inc. (ONCY) quarterly cash flow statement — complete operating, investing & financing history
Oncolytics Biotech Inc. (ONCY) cash flow statement — 27-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -6.99M | -8.07M | -7.29M | -8.59M | -6.83M | -5.83M | -4.73M | -7.48M | -4.83M | -6.82M | -7.47M | -6.12M | -6.03M | -8.46M | -7.83M | -5.94M | -4.25M | -6.92M | -6.25M | -6.34M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -2.31% | -38.34% | -54.09% | -14.96% | -41.33% | 14.49% | 36.63% | -22.07% | 19.87% | 19.44% | 4.6% | -3.12% | -41.98% | -22.38% | -25.22% | 6.27% | -13.77% | -1.77% | -12.28% | -10.54% |
| Net Income | -9.71M | -9.44M | -9.24M | -9.18M | -10.19M | -4.68M | -4.71M | -4.56M | -9.54M | -7.26M | -6.89M | -3.95M | -9.93M | -7.44M | -6.44M | -8.55M | -4.41M | -5.09M | -6.78M | -7.75M |
| Depreciation & Amortization | 17K | 15K | 16K | -134.06K | 230.79K | 120.58K | 19K | 54.14K | 105K | 98K | 123K | 107K | 103K | 96K | 97K | 99.01K | 97.82K | 97.61K | 98K | 96.97K |
| Stock-Based Compensation | 3.08M | 0 | 2.3M | -1.1M | 2.94M | 420.03K | 845K | 767.1K | 445K | 506K | 576K | 759K | 750K | 242K | 317K | 748.98K | 500K | 490.11K | 639K | 1.13M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -707K | 444K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.13M | 2.58M | 816K | 1.73M | -1.68M | -1.66M | -137K | -2.87M | -155K | -382K | -1.24M | -4.57M | 74K | 75K | -251K | -71.66K | -1.25M | -802.81K | 447K | 322.11K |
| Working Capital Changes | 752.14K | -1.22M | -1.18M | 89.29K | 1.87M | -32.96K | -749K | -864.01K | 4.32M | 215K | -33K | 1.53M | 3.67M | -1.88M | -1.55M | 1.84M | 815.52K | -1.61M | -657K | -132.17K |
| Change in Receivables | 17.55K | -250.02K | -388K | 2.92M | 12.98K | 12.08K | -15K | 0 | 1.47M | -1.47M | -87K | 615K | -71K | 171K | -209K | -24.2K | -141.25K | -253.39K | 764K | -614.74K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -187.54K | 730.38K | -813K | 0 | 0 | 0 | 112K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -7.03K | 28 | -6K | -1.28K | -5.03K | 1K | -1K | 5.93K | -32K | -155K | -46K | -3K | 6.77M | 6.79M | 6.67M | -20.35M | -8.57K | -11.64K | -36K | -74.71K |
| Capital Expenditures | 5.97K | 28 | -6K | -970 | -5.03K | 1K | -1K | 5.93K | -32K | -155K | -46K | -3K | 0 | 0 | -5K | 740 | -8.57K | -11.64K | -36K | -74.71K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -13K | 0 | 0 | -314 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.77K | 6.79K | 6.67K | -20.35K | 0 | 0 | 0 | 0 |
| Cash from Financing | 5.31M | 6.7M | 7.61M | 3.58M | 4.35M | 5.8M | 4.18M | 2.95M | -173K | 1.98M | 1.5M | 1.74M | 21.29M | 3.69M | 5.27M | 5.87M | 1.16M | 156.27K | 5.01M | -51.71K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -70.05K | -77.84K | -71.97K | -58.92K | -80K | -65K | -103K | -104K | -102K | -100K | -101K | -101.59K | -96K | -93.67K | -89K | -80.01K |
| Equity Issued (Net) | 5.1M | 6.7M | 7.61M | 2.86M | 2.9M | 4.2M | 4.18M | 2.24M | -93K | 2.04M | 1.6M | 1.47M | 21.33M | 3.45M | 5.37M | 5.97M | 1.26M | 249.94K | 5.09M | -9.2K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 204.26K | 0 | 0 | 718.85K | 1.51M | 1.68M | 71.97K | 770.46K | 0 | 0 | 0 | 375K | 63K | 343K | 0 | -242 | 0 | 0 | 12K | 37.5K |
| Net Change in Cash | -1.69M | -1.38M | 291K | -5.04M | -2.58M | 103.98K | -434K | 638.89K | -5.25M | -4.75M | -5.31M | -5.07M | 22.46M | 1.65M | 4.21M | -20.7M | -1.33M | -5.79M | -1.78M | -6.83M |
| Free Cash Flow | -6.98M | -8.07M | -7.3M | -6.73M | -6.83M | -4.01M | -4.73M | -7.48M | -4.86M | -6.97M | -7.51M | -6.13M | -6.03M | -8.46M | -7.83M | -5.94M | -4.26M | -6.93M | -6.29M | -6.41M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -2.14% | -101% | -54.18% | 9.94% | -40.52% | 42.46% | 37.01% | -22.03% | 19.34% | 17.61% | 4.07% | -3.19% | -41.69% | -22.17% | -24.59% | 7.37% | -8.08% | -1.84% | -12.92% | -11.85% |
| FCF per Share | -0.05 | -0.07 | -0.07 | -0.06 | -0.07 | -0.04 | -0.06 | -0.09 | -0.06 | -0.09 | -0.10 | -0.08 | -0.09 | -0.13 | -0.13 | -0.10 | -0.07 | -0.12 | -0.11 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.72x | 0.85x | 0.79x | 0.94x | 0.66x | 1.29x | 1.00x | 1.64x | 0.51x | 0.94x | 1.08x | 1.55x | 0.81x | 1.53x | 1.65x | 0.94x | 1.26x | 1.73x | 1.17x | 1.03x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27K | 7K | 0 | 0 | 0 | 2K | 0 | 0 | 5.16K |